Given its financial year ended on 31 March, preliminary numbers for DCC (DCC) scarcely reflect the brave new world in which businesses find themselves. But in an encouraging sign of its resilience, the fuel-to-medical products conglomerate surpassed consensus earnings expectations for the period by 4 per cent, and vindicated any investors who have bought into the shares since they collapsed to a five-year low on 17 March.
Join our community of smart investors
- Comprehensive companies coverage
- Actionable commentary, ideas and portfolios
- Tools and data to help you manage and track investments
- Help managing your portfolio